News | Latest Breaking News Stories & Headlines

Dr Ronan Glynn said that NIAC made the recommendation as a precautionary measure and pending further information

Donnelly hoping AZ suspension is only 'short deferral'

The Minister for Health has said he hopes the decision to temporarily suspend the use of AstraZeneca's Covid-19 vaccine "is nothing more than a very short deferral".

Coronavirus • 14 Mar 21

The WHO said that there is no casual link between the AstraZeneca vaccine and blood clots

AZ vaccine target for EU hinges on factory approval

AstraZeneca's new aim of supplying 30 million doses of its Covid-19 vaccine to the EU by the end March hinges on the EU's drug regulator approving supplies from a factory in the Netherlands, an internal document showed.

Coronavirus • 13 Mar 21

The EMA said that European countries could keep using the AstraZeneca vaccine while the issue was investigated

Denmark, Norway, Iceland suspend use of AZ vaccine

Denmark, Norway and Iceland have temporarily suspended the use of AstraZeneca's Covid-19 vaccine over concerns about patients developing post-jab blood clots, as the manufacturer and the European Medicines Agency insisted the vaccine was safe.

Coronavirus • 11 Mar 21

The EU commission now has access to a vaccine portfolio of 2.6 billion doses

EU buys up to 300 million more Moderna jabs

The European Commission has said it had struck a deal for an extra 150 million doses of Moderna's Covid-19 vaccine this year, nearly doubling the number of shots secured from the US biotech firm for 2021.

World • 17 Feb 21

AstraZeneca teamed up with the University of Oxford to develop a Covid-19 vaccine last year

AstraZeneca forecasts 2021 growth on strong Q4 sales

AstraZeneca has forecast 2021 revenue growth after the Covid-19 vaccine developer beat analysts' estimates for fourth-quarter product sales, as a wide range of therapies helped cushion the hit from the pandemic.

Business • 11 Feb 21

Bars and restaurants closed in the Netherlands last October

Dutch government extends night curfew until 3 March

The Dutch government is to extend a night-time curfew intended to slow the spread of Covid-19 until 3 March, the country's justice minister said today.

Coronavirus • 08 Feb 21

British regulators have examined extra trial data

AstraZeneca vaccine works against variant, Oxford says

AstraZeneca and Oxford University's Covid-19 vaccine has similar efficacy against the coronavirus variant currently circulating in Britain and Ireland as it does to the previously circulating variants, the university has said.

Coronavirus • 05 Feb 21

€336 million in EU funds were allocated to AstraZeneca for Covid vaccine production, an official said

EU and AstraZeneca fail to make breakthrough, says EU

The European Union and AstraZeneca have failed to make a breakthrough over delayed Covid-19 vaccine deliveries, the bloc's health chief has said.

Coronavirus • 27 Jan 21

Anyone who has already received their first dose of the Covid vaccine will still receive their second dose as originally planned after 21 days (Pic: RollingNews.ie)

Period of time between Covid vaccine doses increases

The period of time between people receiving the two doses of a Covid-19 vaccine is being increased to 28 days from the current 21 days.

Coronavirus • 15 Jan 21

Professor Karina Butler said the AstraZeneca vaccine would allow easier rollout at a community level

EMA may approve AstraZeneca vaccine by end of month

Europe's medicines regulator has said it expects drug maker AstraZeneca to apply for approval of its Covid-19 vaccine next week.

Coronavirus • 08 Jan 21

Britain's Medicines and Healthcare products Regulatory Agency has approved the vaccine

Germany expects quick approval of AstraZeneca vaccine

Germany expects the European Union to give quick approval to the coronavirus vaccine developed by Oxford University and AstraZeneca that was cleared for use in Britain, its top vaccines official has said.

Coronavirus • 30 Dec 20

AstraZeneca agrees deal for US biotech firm Alexion Pharmaceuticals

AstraZeneca shares fall on $39-billion Alexion bill

AstraZeneca shares fell 9% today as investors moved to price in the British drugmaker's $39 billion deal for US biotech firm Alexion Pharmaceuticals, the company's largest ever and one of this year's biggest mergers globally.

Business • 14 Dec 20

A sub-group of trial participants received a half dose of the experimental vaccine followed by a full dose

'Additional study' needed for AstraZeneca vaccine

AstraZeneca is likely to run an additional global trial to assess the efficacy of its Covid-19 vaccine, its chief executive Pascal Soriot has said, after questions over the results from its late-stage study.

Coronavirus • 26 Nov 20

About a dozen Covid-19 vaccines around the world are currently in the final stages of testing

What progress is being made with Covid-19 vaccines?

Here is everything you need to know about the coronavirus vaccine race.

Coronavirus • 09 Nov 20

AstraZeneca's vaccine candidate is being developed with the University of Oxford

AstraZeneca, J&J vaccine trials back on track in US

Two major clinical trials for experimental Covid-19 vaccines got back on track in the US yesterday, providing a glimmer of hope as the number of cases skyrocket across the country.

World • 24 Oct 20

An unspecified illness occurred in patients during the trials (stock image)

AstraZeneca pauses vaccine trials over safety concern

Trials of a Covid-19 vaccine under development by AstraZeneca and Oxford University have been put on hold owing to a reported side effect in a patient in the UK.

Coronavirus • 09 Sep 20

AstraZeneca is developing its vaccine in conjunction with Oxford University researchers

AstraZeneca's Covid vaccine begins late-stage US study

AstraZeneca said it has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile Covid-19 vaccine candidate.

Business • 01 Sep 20

The UK drugmaker's Covid-19 vaccine candidate is already among the most advanced

AstraZeneca starts trial of COVID-19 antibody treatment

AstraZeneca said today that it had begun testing an antibody-based treatment for the prevention and treatment of Covid-19, with the first participants dosed, adding to recent signs of progress on possible medical solutions to the disease.

Business • 25 Aug 20

Remdesvir is the only drug so far authorised in the EU to treat patients

EU buys enough remdesivir to treat 30,000 Covid cases

The EU has said it had agreed to buy a limited supply of the Covid-19 medicine remdesivir from US drugmaker Gilead to address the short-term needs of European patients, and hoped to be able to order more later.

Coronavirus • 29 Jul 20

Sanofi expects to get approval for the potential Covid-19 vaccine it is developing with GlaxoSmithKline by the first half of next year

Sanofi eyes approval of Covid-19 vaccine by H1 2021

French drugmaker Sanofi said today it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year, faster than previously anticipated.

Business • 23 Jun 20

AstraZeneca signs a second deal with US authorities backing its development of a monoclonal antibody treatment against Covid-19

AstraZeneca wins US backing in race for Covid treatment

AstraZeneca has secured support from the US government to advance the development of antibody-based Covid-19 treatments as the British drugmaker ramps up efforts beyond its potential vaccine to combat the global health crisis.

Business • 09 Jun 20

Experts predict a safe and effective vaccine could take 12 to 18 months to develop

AstraZeneca to make billion vaccine doses if tests work

AstraZeneca expects to be able to deliver a billion doses of a possible Covid-19 vaccine this year and next if tests are successful, adding today that it should shortly get results of an early stage clinical trial.

Business • 21 May 20

A batch of 10 new medicines - which grew 85% in the latest quarter - now offer the company path to growth

AstraZeneca sees years of growth as sales turn corner

Strong demand for AstraZeneca's new drugs - especially those for cancer - drove a return to sales growth in the third quarter and the drugmaker said it now anticipated years of sustained improvement.

Business • 08 Nov 18

AstraZeneca said its earnings per share outlook for the year would not change as a result of the Perrigo deal

AstraZeneca sells US drug rights to Perrigo

AstraZeneca has finalised plans to divest its Crohn's disease drug Entocort by selling US rights to the medicine to Perrigo for $380m.

Business • 23 Nov 15

Pfizer gives no update on acquisition plans after its recent failed efforts to buy rival UK's AstraZeneca

Pfizer beats sales and profit forecasts

Pfizer has reported stronger than expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets.

Business • 28 Oct 14

Astrazeneca